glp 1 origin Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Is GLP-1 the Same as
Description
Clinical trials that investigate dual GLP-1/GIP receptor agonists have presented encouraging evidence for their efficacy and safety in treating MASLD
2015;41:47S-56S
But that does not mean everyone needs lifelong treatment
doi: 10.2337/db15-0443
Distribution Growth Trends 7.4.2
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans
